AMANDA PARCHETA: Open Payments
NPI 1366033458 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,841 in 87 payments from 20 companies in 2025. Trend: 2023 $1,243 · 2024 $1,459 · 2025 $1,841
Food & beverage: $1,798Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $353 |
| GlaxoSmithKline, LLC. | 10 | $265 |
| Viatris Specialty LLC | 13 | $214 |
| Regeneron Healthcare Solutions, Inc. | 13 | $194 |
| Grifols USA, LLC | 4 | $109 |
| JAZZ PHARMACEUTICALS INC. | 3 | $85 |
| Insmed, Inc. | 5 | $84 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $69 |
| United Therapeutics Corporation | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $54 |
Products named: FASENRA, DUPIXENT, NUCALA, YUPELRI, TEZSPIRE, Prolastin-C Liquid, XYWAV, Arikayce.
Industry payments across MI — which companies pay providers there.
